Harris Williams advises Jordi Labs on its sale to RQM+

Harris Williams, a global investment bank specializing in M&A advisory services, announces that it has advised Jordi Labs on its sale to RQM+, a portfolio company of Linden Capital Partners (Linden). Jordi Labs provides a full suite of regulatory, investigative and other analytical chemistry testing services primarily to medical device manufacturers. The transaction was led by Paul Hepper, Nick Owens, Cameron Thomas and Bethel Hailemichael of Harris Williams Healthcare & Life Sciences (HCLS) Group.

“We are delighted to have represented Jordi Labs and believe the company is well positioned to benefit from the growth of outsourced testing services from medical device OEMs who are facing increasing regulatory demands,” said Paul Hepper, Chief Executive Officer. by Harris Williams. “Harris Williams has a history of representing best-in-class, market-leading companies like Jordi Labs that provide critical services to medical device manufacturers.”

“It has been a pleasure working with the President, Dr. Mark Jordi, Vice President Patrick Burke and the rest of the Jordi Labs team,” added Nick Owens, Director at Harris Williams. “Jordi Labs has thrived under the leadership of the Jordi family, and we believe the combination with RQM+ will create significant synergies to help accelerate the growth of the combined platform.”

Jordi Labs was founded in 1980 and provides the highest quality analytical testing services to the medical device, pharmaceutical and other industries, with a particular focus on chemical identification and material solutions. Jordi’s goal is to help his clients overcome their analytical challenges by providing excellent service from his highly trained staff. The company’s proprietary technology and testing techniques differentiate it from its competitors and enable Jordi Labs to solve the most critical and complex problems faced by its customers.

RQM+ is the leading MedTech service provider with the world’s largest team of regulatory and quality experts. The company provides comprehensive regulatory, quality, clinical and laboratory services, supporting market access throughout the product lifecycle for medical devices and diagnostics. With more former FDA, MHRA and Notified Body regulators than any other company, the RQM+ team has deep expertise across all clinical specialties. RQM+ currently works for eight of the top 10 medical device manufacturers and seven of the top 10 IVD companies.

Linden is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is one of the nation’s largest dedicated healthcare private equity firms. Linden’s strategy is based on three elements: (i) healthcare specialization, (ii) integrated private equity and operational expertise, and (iii) its differentiated human capital program. Linden invests in mid-market platforms in the medical products, specialty distribution, pharmaceuticals and healthcare services segments. Since its inception, Linden has invested in over 45 healthcare companies encompassing over 250 transactions in total. The company has raised over $6.5 billion in sponsorship commitments since its inception.

Harris Williams, an investment bank specializing in M&A advisory services, defends sellers and buyers of businesses around the world through critical stages and provides expert advice throughout the life of their businesses . By collaborating as one company across industry groups and geographies, the company helps its clients achieve results that support their goals and strategically create value. Harris Williams is committed to excellence in execution and to building lasting and valuable relationships based on mutual trust. Harris Williams is a subsidiary of PNC Financial Services Group, Inc. (NYSE: PNC).

The Harris Williams HCLS Group has experience across a wide range of industries, including healthcare providers; payers and payer services; outsourced pharmaceutical services; medical device supply chain; health informatics; and pharmacy. For more information on the HCLS Group and other recent transactions, visit the HCLS Group section of the Harris Williams website.

Harris Williams LLC is a registered broker and member of FINRA and SIPC. Harris Williams & Co. Ltd is a limited company incorporated under the laws of England with its registered office at 8th Floor, 20 Farringdon Street, London EC4A 4AB, United Kingdom, registered with the Registrar of Companies for England and Wales (registration number registration 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court in Frankfurt am Main, Germany under number HRB 107540. The registered address is Bockenheimer Landstrasse 33-35, 60325 Frankfurt am Main. -le-Main, Germany (e-mail address: hwgermany@harriswilliams.com). Geschäftsführer/Directors: Jeffery H. Perkins, Paul Poggi. (VAT number DE321666994). Harris Williams is a trading name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH operate.


Add Comment